Curated News: National Institutes of Health (NIH)

Filters close
Newswise: NIH Study Finds Loss of ‘Youth’ Protein May Drive Aging in the Eye
Released: 18-Jul-2022 4:55 PM EDT
NIH Study Finds Loss of ‘Youth’ Protein May Drive Aging in the Eye
NIH, National Eye Institute (NEI)

Loss of the protein pigment epithelium-derived factor (PEDF), which protects retinal support cells, may drive age-related changes in the retina, according to a new study in mice from the National Eye Institute (NEI).

Newswise: NIH Study Finds Loss of ‘Youth’ Protein May Drive Aging in the Eye
Released: 18-Jul-2022 4:55 PM EDT
NIH Study Finds Loss of ‘Youth’ Protein May Drive Aging in the Eye
NIH, National Eye Institute (NEI)

Loss of the protein pigment epithelium-derived factor (PEDF), which protects retinal support cells, may drive age-related changes in the retina, according to a new study in mice from the National Eye Institute (NEI).

Newswise: Wistar Scientists Reveal New Function of Enzyme ADAR1 Linking it to Age-Related Diseases via a Role Independent of RNA-editing During Aging
18-Jul-2022 8:05 AM EDT
Wistar Scientists Reveal New Function of Enzyme ADAR1 Linking it to Age-Related Diseases via a Role Independent of RNA-editing During Aging
Wistar Institute

Published today in Nature Cell Biology, Wistar scientists revealed a novel ADAR1-SIRT1-p16INK4a axis in regulating cellular senescence and its potential implications in tissue aging.

14-Jul-2022 9:55 AM EDT
Whole blood exchange could offer disease-modifying therapy for Alzheimer’s disease, study finds
University of Texas Health Science Center at Houston

A novel, disease-modifying therapy for Alzheimer’s disease may involve the whole exchange of blood, which effectively decreased the formation of amyloid plaque in the brains of mice, according to a new study from UTHealth Houston.

Newswise: A type of ‘step therapy’ is an effective strategy for diabetic eye disease
11-Jul-2022 3:40 PM EDT
A type of ‘step therapy’ is an effective strategy for diabetic eye disease
NIH, National Eye Institute (NEI)

Clinical trial results from the DRCR Retina Network suggest that a specific step strategy, in which patients with diabetic macular edema start with a less expensive medicine and switch to a more expensive medicine if vision does not improve sufficiently, gives results similar to starting off with the higher-priced drug.

8-Jul-2022 2:05 PM EDT
Preoperative Combination Chemotherapy Improved Survival in Patients with Pancreatic Cancer
University of Texas MD Anderson Cancer Center

In a study of patients with borderline resectable pancreatic cancer, combination chemotherapy with modified FOLFIRINOX before surgery increased survival relative to historical data and compared favorably to FOLFIRINOX plus hypofractionated radiotherapy, according to research from The University of Texas MD Anderson Cancer Center published today in JAMA Oncology.

12-Jul-2022 7:05 AM EDT
Study identifies new approach for developing simple-to-use, ‘shelf-available’ COVID treatment options
Uniformed Services University of the Health Sciences (USU)

An array of new, simple “shelf-available” SARS-CoV-2 treatment options could soon be available in the fight against COVID thanks to a new study, “Engineered ACE2-Fc counters murine lethal SARS-CoV-2 infection through direct neutralization and Fc-effector activities,” published July 13 in Science Advances.

Newswise: Faculty Receives $3 Million National Institutes of Health Grant to Develop Novel Bayesian Machine Learning Methods
Released: 12-Jul-2022 5:05 PM EDT
Faculty Receives $3 Million National Institutes of Health Grant to Develop Novel Bayesian Machine Learning Methods
Rutgers School of Public Health

Rutgers School of Public Health associate professor, Liangyuan Hu, has received a $3,301,474 grant (R01HL159077) from the National Institutes of Health National Heart, Lung, and Blood Institute, part of the National Institutes of Health.

Newswise: UTSW researchers show effectiveness of migraine drug in weight loss
Released: 11-Jul-2022 3:05 PM EDT
UTSW researchers show effectiveness of migraine drug in weight loss
UT Southwestern Medical Center

Triptans, a commonly prescribed class of migraine drugs, may also be useful in treating obesity, a new study by scientists at UT Southwestern suggests. In studies on obese mice, a daily dose of a triptan led animals to eat less food and lose weight over the course of a month, the team reported in the Journal of Experimental Medicine.

Newswise: New $3.25M NIH grant to support research in oral manifestations of HIV, including mouth cancer
Released: 11-Jul-2022 1:05 PM EDT
New $3.25M NIH grant to support research in oral manifestations of HIV, including mouth cancer
Case Western Reserve University

Researchers at the Case Western Reserve University School of Dental Medicine will use a $3.25 million grant from the National Institutes of Health (NIH) to better understand how HIV impacts the human body, from mouth lesions to oral cancer.

Newswise: John P. Hussman Institute to Lead International Genetic Study of Alzheimer’s Disease in People of Hispanic and African Ancestry
Released: 11-Jul-2022 11:40 AM EDT
John P. Hussman Institute to Lead International Genetic Study of Alzheimer’s Disease in People of Hispanic and African Ancestry
University of Miami Health System, Miller School of Medicine

To build a resource that greatly expands Alzheimer’s disease genetic studies in the currently underrepresented African ancestry populations and Hispanic/Latinx groups, the John P. Hussman Institute for Human Genomics (HIHG) at the University of Miami Miller School of Medicine will lead a major five-year, international, multi-site initiative with Case Western Reserve University, Columbia University, Wake Forest University, the University of Pennsylvania, and the University of Ibadan, which is the lead institution for the African Dementia Consortium (AfDC).

8-Jul-2022 3:25 PM EDT
Poziotinib is active in EGFR exon 20 mutant non-small cell lung cancer with efficacy highly dependent on insertion location
University of Texas MD Anderson Cancer Center

A Phase II clinical trial of poziotinib for non-small cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) exon 20 mutations, led by researchers at The University of Texas MD Anderson Cancer Center, found the drug had significant antitumor activity and the efficacy was highly dependent on the location of the exon 20 loop insertion, which may impact future clinical trials for EGFR exon 20 targeted therapies.

Released: 8-Jul-2022 3:45 PM EDT
Immune system uses two-step verification to defend against HIV
Scripps Research Institute

Human immunodeficiency virus 1, more commonly known as HIV-1, is known for its uncanny ability to evade the immune system.

Released: 7-Jul-2022 2:05 PM EDT
Unexpected Link Between Most Common Cancer Drivers May Yield More Effective Drugs
University of Wisconsin–Madison

Two of the most common genetic changes that cause cells to become cancerous, which were previously thought to be separate and regulated by different cellular signals, are working in concert, according to new research from the University of Wisconsin–Madison. To date, researchers have focused on finding drugs that block one or the other to treat cancer.

Released: 7-Jul-2022 11:05 AM EDT
Both Gun Owners and Non-Gun Owners Trust Kids’ Doctors in Gun Safety Talks
Perelman School of Medicine at the University of Pennsylvania

New research shows that parents are open to talking about gun safety measures with their children’s pediatricians and willing to change firearm storage practices

   
Newswise: Brain Regions Vulnerable to Disease May Lack Adequate Energy From Blood Supply
Released: 7-Jul-2022 8:05 AM EDT
Brain Regions Vulnerable to Disease May Lack Adequate Energy From Blood Supply
Penn State College of Medicine

Areas of the brain vulnerable to neurodegenerative disorders like Alzheimer’s disease tend to have less dense vascular networks — which supply the brain with energy via blood — than other areas of the brain, according to Penn State researchers.

Newswise: NIH Researchers Decode Retinal Circuits for Circadian Rhythm, Pupillary Light Response
Released: 6-Jul-2022 4:20 PM EDT
NIH Researchers Decode Retinal Circuits for Circadian Rhythm, Pupillary Light Response
NIH, National Eye Institute (NEI)

The eye’s light-sensing retina taps different circuits depending on whether it is generating image-forming vision or carrying out a non-vision function such as regulating pupil size or sleep/wake cycles, according to a new mouse study from the National Eye Institute (NEI) and the National Institute of Mental Health (NIMH).

Newswise: NIH Researchers Decode Retinal Circuits for Circadian Rhythm, Pupillary Light Response
Released: 6-Jul-2022 4:20 PM EDT
NIH Researchers Decode Retinal Circuits for Circadian Rhythm, Pupillary Light Response
NIH, National Eye Institute (NEI)

The eye’s light-sensing retina taps different circuits depending on whether it is generating image-forming vision or carrying out a non-vision function such as regulating pupil size or sleep/wake cycles, according to a new mouse study from the National Eye Institute (NEI) and the National Institute of Mental Health (NIMH).

Released: 6-Jul-2022 2:05 PM EDT
Grant to Help Researchers Uncover Signs of Heart Damage
Wake Forest University School of Medicine

Researchers at Wake Forest University School of Medicine receive $3.1 million grant to lead a multi-site study to look for the earliest signs of heart vessel damage in young, pre-menopausal breast cancer survivors.

Newswise: A Rhythmic Small Intestinal Microbiome Prevents Obesity and Type 2 Diabetes
Released: 5-Jul-2022 2:00 PM EDT
A Rhythmic Small Intestinal Microbiome Prevents Obesity and Type 2 Diabetes
UC San Diego Health

UC San Diego researchers found that in mice how much they ate and when altered the nature of their gut microbiome: too much food too frequently resulted in poorer microbial and metabolic health.



close
2.45382